Inventiva (IVEVF) Change in Receivables (2019 - 2025)
Inventiva (IVEVF) posted Change in Receivables of -$16.4 million for Q2 2025, down 307.65% on a QoQ basis from -$4.0 million in Q4 2022.
Analysis
Inventiva (IVEVF) Change in Receivables (2019 - 2025) Analysis & Trends
Inventiva has reported Change in Receivables for 5 years, with the latest figure at -$16.4 million in Q2 2025.
- On a quarterly basis, Change in Receivables changed N/A year-over-year to -$16.4 million in Q2 2025; TTM through Jun 2025 was -$16.4 million, a N/A change from a year earlier, with the FY2025 full-year figure at $989437.0, down 67.0% from the prior year.
- Change in Receivables was -$16.4 million for Q2 2025 at Inventiva, down from -$4.0 million in the prior quarter.
- The five-year high for Change in Receivables was $4.1 million in Q3 2022, with the low at -$16.4 million in Q2 2025.
- Average Change in Receivables over 3 years is -$2.8 million, with a median of -$133428.9 recorded in 2021.
- The sharpest annual moves came in 2021 and 2022: Change in Receivables surged 132.11% in 2021, then tumbled 4718.42% in 2022.
- Over 3 years, Change in Receivables stood at -$83509.9 in 2021, then sank by 4718.42% to -$4.0 million in 2022, then tumbled by 307.65% to -$16.4 million in 2025.
- The last three Change in Receivables figures came in at -$16.4 million (Q2 2025), -$4.0 million (Q4 2022), and $4.1 million (Q3 2022), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.47 Bn | 624.71 Bn | 17.26 Bn | 1.35 Bn |
| 2 | AbbVie | 439.99 Bn | 433.42 Bn | 12.70 Bn | 1.37 Bn |
| 3 | Merck | 365.45 Bn | 358.31 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 266.57 Bn | 258.88 Bn | 11.24 Bn | - |
| 5 | Pfizer | 159.03 Bn | 147.33 Bn | 10.94 Bn | - |
| 6 | Sanofi | 52.43 Bn | 45.05 Bn | 10.79 Bn | - |
| 7 | Revolution Medicines | 44.23 Bn | 44.23 Bn | - | - |
| 8 | Incyte | 25.32 Bn | 20.79 Bn | 1.57 Bn | 73.80 Mn |
| 9 | United Therapeutics | 21.44 Bn | 18.77 Bn | 683.80 Mn | -1.70 Mn |
| 10 | Inventiva | 693.72 Mn | 693.72 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2025 | -16.40 Mn |
| Dec 31, 2022 | -4.02 Mn |
| Sep 22, 2022 | 4.06 Mn |
| Dec 31, 2021 | -83,509.88 |
| Jun 30, 2021 | 95,137.44 |
| Mar 31, 2021 | -183,347.89 |
| Dec 31, 2020 | -482,877.39 |
| Jun 30, 2020 | -296,292.77 |
| Mar 31, 2020 | -150,135.71 |
| Dec 31, 2019 | 1.81 Mn |